Lisa LeCointe-Cephas has come full circle as chief compliance officer at Johnson & Johnson Innovative Medicine, the health ...
Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate ...
Maharashtra Medical Education Minister Hasan Mushrif on Thursday directed immediate measures to reduce the mortality rate in government hospitals.
Minister Hasan Mushrif reiterated that improving healthcare services and saving lives in government hospitals remains a top ...
After an offseason filled with speculation about LeBron James’ future, the Los Angeles Lakers began without their biggest ...
The prolonged recovery has fueled speculation among fans that the injury could push LeBron James toward retirement.
The EPIC study will evaluate treatment with IMAAVY™ versus efgartigimod in adults with gMG and will include a treatment-switch arm The Company also announced new data from the pivotal Vibrance-MG ...
Zacks Investment Research on MSN
JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio?
Johnson & Johnson JNJ and Merck MRK are leading U.S. healthcare giants, making them natural peers for a head-to-head ...
A myasthenia gravis treatment revolution has taken place in the past four years, spurred by an initial approval for argenx’s ...
This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback